Trial
NCT05839509
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
GH Research Ireland Limited
Collaborators
—
Condition
Bipolar II Disorder
Intervention
GH001
Why stopped
Recruitment of this patient population was more challenging than anticipated. The sponsor concluded that a sufficient amount of patients have completed the trial to demonstrate proof of concept in this patient population.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-18